User profiles for Mitchell G. Lawrence

Mitchell Lawrence

Monash University
Verified email at monash.edu
Cited by 5316

Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression

…, ML Ackland, T Blick, MG Lawrence… - Journal of cellular …, 2007 - Wiley Online Library
Like a set of bookends, cellular, molecular, and genetic changes of the beginnings of life
mirror those of one of the most common cause of death—metastatic cancer. Epithelial to …

[HTML][HTML] Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling

R Pidsley, E Zotenko, TJ Peters, MG Lawrence… - Genome biology, 2016 - Springer
Background In recent years the Illumina HumanMethylation450 (HM450) BeadChip has
provided a user-friendly platform to profile DNA methylation in human samples. However, …

Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus

MG Lawrence, J Lai, JA Clements - Endocrine reviews, 2010 - academic.oup.com
The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific
expression profiles and putative proteolytic functions. The kallikrein family is also …

[HTML][HTML] Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories

…, N Yu, F Yousif, M Papargiris, MG Lawrence… - Nature …, 2017 - nature.com
Germline mutations in the BRCA2 tumour suppressor are associated with both an increased
lifetime risk of developing prostate cancer (PCa) and increased risk of aggressive disease. …

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates …

…, A Sliwinski, H Thorne, S Hunter, J Li, G Mitchell… - European Urology, 2015 - Elsevier
Background Intraductal carcinoma of the prostate (IDC-P) is a distinct clinicopathologic entity
associated with aggressive prostate cancer (PCa). PCa patients carrying a breast cancer 2, …

Patient-derived models of abiraterone-and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy

MG Lawrence, D Obinata, S Sandhu, LA Selth… - European urology, 2018 - Elsevier
… Author links open overlay panel Mitchell G. Lawrence a b c † , Daisuke Obinata a † , … (G)
GSEA of up- and downregulated genes in the Beltran signature in tumour 201.2 versus tumour …

A preclinical xenograft model of prostate cancer using human tumors

MG Lawrence, RA Taylor, R Toivanen, J Pedersen… - Nature protocols, 2013 - nature.com
Most cases of prostate cancer are now diagnosed as moderate-grade localized disease.
These tumor specimens are important tools in the discovery and translation of prostate cancer …

Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories

LH Porter, MG Lawrence, D Ilic, D Clouston, DM Bolton… - European urology, 2017 - Elsevier
Intraductal carcinoma of the prostate (IDC-P) is associated with poor prognosis. While it is
often regarded as a rare pathology, the prevalence of IDC-P remains unclear, with variable …

[HTML][HTML] The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology

…, DL Goode, M Frydenberg, MG Lawrence… - Nature …, 2021 - nature.com
Preclinical testing is a crucial step in evaluating cancer therapeutics. We aimed to establish
a significant resource of patient-derived xenografts (PDXs) of prostate cancer for rapid and …

Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells

MG Lawrence, NV Margaryan, D Loessner… - The …, 2011 - Wiley Online Library
BACKGROUND Nodal is a member of the transforming growth factor β (TGFβ) superfamily
that directs embryonic patterning and promotes the plasticity and tumorigenicity of tumor cells, …